Ivosenib 250mg (ivosidenib)

Ivosenib 250 mg (Ivosidenib) - Targeted AML Therapy

Ivosenib 250 mg (Ivosidenib) is an advanced oral oncology medication used for the targeted treatment of specific forms of acute myeloid leukemia (AML). As a precision medicine, it is designed to help patients whose cancer carries a specific genetic mutation.

This medication is manufactured by Everest Pharmaceuticals Ltd., a premier pharmaceutical company in Bangladesh, and is supplied globally by Mediaid Pharmacy. We are dedicated to ensuring that patients and healthcare providers around the world have reliable access to genuine, high-quality cancer treatments.

What is Ivosenib 250 mg (Ivosidenib)?

Ivosenib contains the active ingredient Ivosidenib, which is an IDH1 inhibitor. It targets a specific protein called isocitrate dehydrogenase-1 (IDH1).

In some patients with AML, the IDH1 gene is mutated, producing an abnormal protein that prevents young blood cells from developing into healthy, mature blood cells. This leads to an accumulation of immature leukemia cells. Ivosenib works by blocking this abnormal IDH1 protein, allowing the leukemia cells to differentiate (mature) into normal, functioning blood cells.

Indications for Use

Ivosenib 250 mg is indicated for the treatment of adult patients with Acute Myeloid Leukemia (AML) who have a susceptible IDH1 mutation. Specific indications typically include:

• Relapsed or Refractory AML: For patients whose disease has come back or has not improved after previous treatments.
• Newly Diagnosed AML: For certain adult patients who are 75 years or older, or who have comorbidities that preclude the use of intensive induction chemotherapy.

A doctor must confirm the presence of the IDH1 mutation through an FDA-approved test or validated diagnostic test before starting treatment.

Dosage & Administration

Ivosenib is available as a 250 mg tablet. The standard recommended dosage is typically 500 mg taken orally once daily. This means taking two 250 mg tablets at the same time each day.

• Ivosenib can be taken with or without food. However, avoid taking it with a high-fat meal.
• Tablets should be swallowed whole. Do not split, crush, or chew the tablets.
• If a dose is vomited, do not take a replacement dose; wait until the next scheduled dose.

Always follow the specific dosage instructions provided by your qualified oncologist.

Manufacturer – Everest Pharmaceuticals Ltd.

Everest Pharmaceuticals Ltd. is a leading pharmaceutical manufacturer in Bangladesh, known for its commitment to oncology and high-tech formulations. Operating facilities that adhere to international Good Manufacturing Practices (GMP), Everest ensures that specialized drugs like Ivosenib meet rigorous global standards for quality and efficacy.

Supplier – Mediaid Pharmacy

Mediaid Pharmacy is your trusted global supplier and distributor of specialized oncology medicines, including Ivosenib 250 mg. We bridge the gap in global healthcare by delivering essential treatments to those who need them most.

Mediaid Pharmacy is known for:

• Worldwide Shipping: We securely ship medications to patients, pharmacies, and hospitals across the globe.
• Guaranteed Authenticity: We source Ivosenib 250 mg directly from Everest Pharmaceuticals to ensure 100% product genuineness.
• Patient-Centric Service: Our professional team provides dedicated support and ensures a seamless, confidential ordering process.
• Competitive Pricing: We aim to make advanced cancer therapies more accessible.

Why Choose Ivosenib 250 mg from Mediaid Pharmacy?

• Targeted Mechanism: Specifically treats cancers with the IDH1 mutation.
• Oral Convenience: Taken as a daily oral tablet, avoiding the need for infusion.
• High-Quality Manufacturing: Produced by Everest Pharmaceuticals under strict quality control.
• Global Availability: Distributed efficiently by Mediaid Pharmacy with reliable shipping options.

Frequently Asked Questions (FAQs)

Q: How many tablets do I take per day?
A: The standard dose is usually 500 mg once daily, which equals two 250 mg tablets. Always follow your doctor's prescription.

Q: What happens if I miss a dose?
A: Take the missed dose as soon as possible at least 12 hours before the next scheduled dose. Do not take two doses within 12 hours.

Q: How is the product packaged?
A: Ivosenib 250 mg comes in a box containing 1 bottle of 60 tablets.

Conclusion

Ivosenib 250 mg (Ivosidenib) represents a significant advancement in the treatment of IDH1-mutated AML. By targeting the specific genetic driver of the disease, it offers a potent therapeutic option for patients. Manufactured by Everest Pharmaceuticals and supplied by Mediaid Pharmacy, this medication provides a reliable path to treatment.

Contact Us to Order or Inquire

For the latest pricing, bulk orders, or to speak with our pharmacy team about Ivosenib 250 mg (Ivosidenib), please contact us. We are available 24/7 to support your healthcare needs.

WhatsApp/WeChat: +8801773428128